Cell Therapy for Diabetic Foot Ulcer

Exclusion Criteria

• •Patients with non-diabetic ulcers.
• •Toe ulcers.
• •Patient with grade IV and V renal insufficiency.
• •Pregnant or breastfeeding women, or those who are planning to conceive children.
• •Clinical evidence of infection.
• •Any condition or circumstance that might interfere with adherence to the treatment regimen (compliance with scheduled visits, psychiatric disorders, or drug and/or alcohol abuse)
• •History of hepatitis B or hepatitis C and HIV (by internal laboratory biosafety protocols)
• •Allergy to penicillin, streptomycin, and gentamicin
• •Subjects undergoing treatment with immunosuppressants and corticoids.
• •Subjects on anticoagulant treatment with acenocoumarol and warfarin.
• •Having received any experimental treatment in the last three months (drug, biological product, medical device or cell therapy), except for the use of vaccines administered against COVID-19 (e.g. mRNA technologies, viral vector or inactivated virus).